Rocket Pharmaceuticals, Inc. (RCKT) stock
RCKTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.11+0.00 (0.00%)
Close on Nov 18, 2026Market cap $231.62MP/E –Yield –
Rocket Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Rocket Pharmaceuticals's price to book ratio was 0.7× on Nov 11, 2026, against 1.2× a year earlier. Over the last 5 years it ranged from 0.6× to 5.4×, with a median of 2.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.7× | −0.5 |
| 2025 | Dec 31, 2025 | 1.2× | −2.3 |
| 2024 | Dec 31, 2024 | 3.5× | −1.5 |
| 2023 | Dec 29, 2023 | 5.0× | +1.4 |
| 2022 | Dec 30, 2022 | 3.6× | +0.7 |
| 2021 | Dec 31, 2021 | 2.9× | −9.6 |
| 2020 | Dec 31, 2020 | 12.5× | +7.9 |
| 2019 | Dec 31, 2019 | 4.6× | +0.5 |
| 2018 | Dec 31, 2018 | 4.1× | +2.7 |
| 2017 | Dec 29, 2017 | 1.4× | −0.5 |
| 2016 | Dec 30, 2016 | 1.9× | −0.6 |
| 2015 | Dec 31, 2015 | 2.6× | – |
See a number that looks wrong?